ELICIO THERAPEUTICS INC. - COMMON STOCK
4.6000
04-October-24 13:15:00
15 minutes delayed
Stocks
-0.2800
-5.74%
Today's range
4.6000 - 4.9000
ISIN
N/A
Source
NASDAQ
-
Elicio Therapeutics Announces First Patient Dosed in Randomized Phase 2 Pancreatic Cancer Study
11 Jan 2024 08:30:00 By Nasdaq GlobeNewswire
-
09 Jan 2024 06:00:00 By Nasdaq GlobeNewswire
-
Elicio Therapeutics Announces $7.0 Million Private Placement Financing
22 Dec 2023 09:00:32 By Nasdaq GlobeNewswire
-
04 Dec 2023 08:00:00 By Nasdaq GlobeNewswire
-
Elicio Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
09 Nov 2023 16:30:00 By Nasdaq GlobeNewswire
-
Elicio Therapeutics Completes Reverse Merger and Provides a Corporate Update
06 Jun 2023 08:00:01 By Nasdaq GlobeNewswire
-
Elicio Therapeutics Reports Inducement Grant to New Chief Financial Officer
02 Jun 2023 16:30:00 By Nasdaq GlobeNewswire
-
Elicio Therapeutics Announces Completion of Merger with Angion Biomedica
01 Jun 2023 16:04:00 By Nasdaq GlobeNewswire